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Abstract Nutrition, bacterial composition of the
gastrointestinal tract, and general health status can all
inﬂuence the metabolic proﬁle of an organism. We
previously demonstrated that feeding pasteurized
transgenic goats’ milk expressing human lysozyme
(hLZ) can positively impact intestinal morphology
and modulate intestinal microbiota composition in
young pigs. The objective of this study was to further
examine the effect of consuming hLZ-containing
milk on young pigs by proﬁling serum metabolites.
Pigs were placed into two groups and fed a diet of
solid food and either control (non-transgenic) goats’
milk or milk from hLZ-transgenic goats for 6 weeks.
Serum samples were collected at the end of the
feeding period and global metabolite proﬁling was
performed. For a total of 225 metabolites (160
known, 65 unknown) semi-quantitative data was
obtained. Levels of 18 known and 4 unknown
metabolites differed signiﬁcantly between the two
groups with the direction of change in 13 of the 18
known metabolites being almost entirely congruent
with improved health status, particularly in terms of
the gastrointestinal tract health and immune response,
with the effects of the other ﬁve being neutral or
unknown. These results further support our hypoth-
esis that consumption of hLZ-containing milk is
beneﬁcial to health.
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Introduction
A myriad of cellular processes are required for the
normal growth, maintenance, and function of a cell or
organism. Metabolites, small, low molecular weight
compounds, are integral to these processes and can be
of endogenous origin, or may be xenobiotic in nature,
coming from food or pharmaceuticals (Dunn 2008;
Gibney et al. 2005). The ﬁeld of metabolomics
involves the global proﬁling, identiﬁcation, quantiﬁ-
cation, and study of all metabolites, or as many as
possible, in a speciﬁc tissue or matrix of an organism
under a deﬁned set of conditions at a certain point in
time (Whitﬁeld et al. 2004; Goodacre 2007).
The metabolic proﬁle of an organism can serve as
an indicator of its physiological state at a given time
point (Whitﬁeld et al. 2004). The presence of speciﬁc
metabolites and their levels is dependent upon the
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DOI 10.1007/s11248-009-9334-4inputs and interactions between a number of internal
and external factors; therefore, changes in any of
these factors are reﬂected in the composition of the
metabolome (Gibney et al. 2005; Whitﬁeld et al.
2004; Goodacre 2007). Diet and nutrition, in partic-
ular, can both have major effects on the metabolome
(Gibney et al. 2005). Various studies have docu-
mented that changes in consumption of certain foods,
including milk, may result in subsequent changes in
metabolic proﬁles (Roura et al. 2008; Bertram et al.
2007). Another major contribution to the metabolome
of humans and other mammals is the gastrointestinal
tract (GI) microbiota (Gibney et al. 2005; Goodacre
2007), which may contain an estimated 10
13–10
14
organisms from more than 1,000 species (Gill et al.
2006). These microbiota have their own metabolic
networks and processes (Gill et al. 2006; Nicholson
et al. 2004), and as such, can supply metabolite
products directly to their host (Gibney et al. 2005;
Goodacre 2007; Gill et al. 2006). The microbes can
also metabolize molecules already processed by the
hosts, or other microbes, transforming them and
creating new metabolites. The metabolic functions of
the microbial population are necessary for maintain-
ing the host’s health as they are capable of synthe-
sizing nutrients essential to their mammalian hosts
(Gibney et al. 2005; Gill et al. 2006). Microbial
metabolites from intestinal microbiota have been
detected in both human serum and urine (Nicholson
et al. 2004), while Li et al. (2008) have shown that
differences in GI microbial populations are reﬂected
in changed urine metabolic proﬁles from human
research subjects.
Recent studies have demonstrated a link between
the GI tract microbial population, metabolic proﬁles,
and the host’s health. Feeding Lactobacillus species
to rats and mice affected lipid metabolite levels in the
blood and liver and overall had an anti-diabetic effect
(Yadav et al. 2007). Differences in the microbiota
and the effect on the metabolome are also correlated
with obesity and cardiovascular disease (Ley et al.
2006; Ordovas and Mooser 2006). In addition, Martin
et al. (2007) showed that introducing a human baby
ﬂora to mice resulted in changes in the metabolomes
of several different tissues, including plasma, liver,
and the gut.
Lysozyme, a 1,4-b-N-acetylmuramidase, cleaves a
glycosidic linkage in the peptidoglycan component of
bacterial cell walls, ultimately causing the cell
membrane to lose integrity and the cell to die (Ellison
and Giehl 1991; Blake et al. 1967). Notably,
lysozyme is an important non-speciﬁc immune
defense factor in human milk, where it occurs at
high levels (400 mg l
-1) compared to the milk of
dairy animals (Chandan et al. 1968). Studies indicate
that lysozyme contributes to the establishment of the
biﬁdobacteria- and lactobacilli-rich GI biota in
breastfed infants that is protective against GI illness
and may aid in the maturation of the intestinal tract
(Coppa et al. 2006; Solis et al. 2002; Schiffrin and
Blum 2002; Newburg and Walker 2007). Lysozyme
is active against a number of bacteria, particularly
gram-positive species; however, it has also been
shown to be effective against gram-negative species
in vitro (Ellison and Giehl 1991; Masschalck and
Michiels 2003; Maga et al. 2006a). Evidence suggests
that lysozyme may be involved in modulating the
inﬂammatory response as well (Brandenburg et al.
1998; Ginsburg 2002; Takada et al. 1994a, b; Muller
et al. 2005). Also, addition of lysozyme to the diet has
been shown to increase feed efﬁciency and positively
affect the GI morphology in young chicks (Humphrey
et al. 2002).
Bovine and caprine milk have very low levels of
lysozyme (0.16 and 0.23 mg l
-1, respectively) rel-
ative to human milk (Chandan et al. 1968). Our lab
previously developed a line of transgenic dairy
goats which express hLZ at 67% (270 mg l
-1)o f
the level found in human milk (Maga et al. 2006a).
We have shown that feeding pasteurized milk from
these goats can positively impact the health of
young pigs and goats (Maga et al. 2006b; Brundige
et al. 2008). In both species, consumption of hLZ-
containing milk signiﬁcantly changed the population
of E. coli and coliforms in the small intestine
(Maga et al. 2006b). In a second study, several
measures of GI health, including morphology and
duodenum villi intraepithelial lymphocyte count,
were improved in weaned young pigs that were
reared on a diet that included hLZ-containing milk
(Brundige et al. 2008). Considering that changes in
diet, GI microbiota, and general health status are
reﬂected in changes in the metabolome, and taking
into account the previous outcome we saw in the
young pigs that consumed hLZ transgenic milk, we
proﬁled serum metabolites in order to further
investigate the effects of pasteurized hLZ transgenic
milk on young pigs.
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Animals and diet
We previously described the pigs used for this
metabolomic proﬁling study, their selection, diet,
and treatment during rearing (Brundige et al. 2008).
Brieﬂy, at 12 days of age, 12 pigs were weaned
from sows and distributed into two feeding groups,
each balanced for weight, sex, and genetic back-
ground. Two pools of milk, one from hLZ trans-
genic does and one from non-transgenic control
does, were formed prior to pasteurization. All milk
was pasteurized prior to feeding to the pigs. The
pigs were fed 8 oz (0.24 l) of goat milk per animal
twice a day, and solid feed and water were available
ad libitum to all animals throughout the study. The
amount of solid food consumed by pigs was not
measured. Pigs were ﬁrst weaned onto Pig A2000
Pellet Denagard/CTC starter diet (Akey, Lewisburg,
OH, USA), containing lactose, cereal food ﬁnes,
soybean meal, oat groats, ground corn, animal
plasma, poultry meal, ﬁsh meal, cheese meal,
vegetable and animal fat, and the antibiotics tiam-
ulin hydrogen fumarate and chlorotetracycline. This
diet provided 21% crude protein, 8% crude fat, and
2% crude ﬁber. After 2 weeks, the pigs were
switched to a standard grower diet (Associated
Feed, Turlock, CA, USA). The grower diet con-
tained wheat millrun, fat mixer, ground corn, blood
meal, whole dried whey, soybean meal, Akey Swine
Micro 4 mix, and Tylan 40 antibiotic. This diet
provided 20% protein, 7% crude fat, 2% crude ﬁber,
and ME
2 of 13.6 MJ kg
-1. All animals under study
were monitored at each feeding for any signs of
illness and were cared for and housed under
AAALAC-approved conditions. After 6-weeks, the
pigs were necropsied at the California Animal
Health and Food Safety Laboratory (UC Davis,
Davis, CA, USA) by an American College of
Veterinary Pathologist (ACVP) board-certiﬁed ani-
mal pathologist.
Blood collection and serum preparation
Whole blood was collected from each animal imme-
diately before necropsy via venipuncture into addi-
tive-free blood collection tubes (Vacutainer, BD).
Samples were allowed to clot for 4 h at 4C. After
coagulation, samples were centrifuged in 1.5 ml
aliquots at 1,500 RPM to separate serum from clotted
material. The serum aliquots from each pig were
pooled post-centrifugation and before transferring to
clean microcentrifuge tubes for storage at -70C
until use.
Metabolite proﬁling
Three types of mass spectrometry analysis were
applied to all samples: GC-MS (gas chromatogra-
phy-mass spectrometry), LC-MS/MS (liquid chro-
matography-mass spectrometry/mass spectrometry),
and SPE-LC-MS/MS (Solid phase extraction-LC-
MS/MS). For mass spectrometry-based metabolite
proﬁling analyses proteins were removed from
plasma samples by precipitation. Subsequently sam-
ples were extracted and polar and non-polar frac-
tions were obtained by adding water and a mixture
of ethanol and dichloromethane. For GC-MS anal-
ysis, the non-polar fraction was treated with meth-
anol under acidic conditions to yield fatty acid
methyl esters. Both fractions were further deriva-
tized with O-methyl-hydroxyamine hydrochloride
and pyridine to convert oxo-groups to O-methyloxi-
mes and then subsequently with a silylating agent
before analysis. For LC-MS analysis, both fractions
were reconstituted in appropriate solvent. High
performance liquid chromatography (HPLC) was
performed by gradient elution using methanol/water/
formic acid on reversed phase separation columns.
Mass spectrometric detection technology which
allows targeted and high sensitivity multiple reac-
tion monitoring (MRM) proﬁling was performed in
parallel to a full screen analysis. Steroids and their
metabolites were measured by online SPE-LC-MS/
MS. Catecholamines and their metabolites were
measured by online SPE-LC-MS/MS as described
by Yamada et al. (2002). For both, absolute
quantiﬁcation was performed by means of stable
isotope-labeled standards.
Data analysis and statistics
Reference samples (pool samples) were generated
from equal amounts of individual experimental sam-
ples and ran through the pre-analytical and analytical
process together with individual samples. GC-MS
and LC-MS/MS proﬁling data were expressed as
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123ratios relative to pool samples. For catecholamines
and steroids, quantitative data (levels in ng ml
-1)
were obtained, except for cortisol, which was nor-
malized to pool samples.
Metabolite proﬁling data was analyzed by using
univariate statistics to determine differences between
treatment groups. All data were log10-transformed.
Means of the treated groups were compared to the
means of the respective untreated control groups
using Student’s t-test (P\0.05). Median values were
calculated for each treatment group as were a ratio of
median values as a measure of effect size and
direction. t-tests were calculated on the basis of log-
transformed data to ensure normal distribution.
Heteroskedastic t-test (Welch test, assuming unequal
variance between treatment groups) were calculated,
and a signiﬁcance level of P\0.05 was considered
signiﬁcant. The P value was not adjusted for multiple
testing; therefore, results must be viewed in compar-
ison to the false-positive rate, i.e. at P = 0.05 and
225 metabolites, 11.25 signiﬁcant changes would be
expected to arise by chance, whereas 22 were
observed.
Results
We quantiﬁed a total of 225 metabolites in the pig
serum samples analyzed for this study. We have
identiﬁed 160 of these metabolites, with the remain-
ing 65 metabolites being unknown. The 160 known
metabolites fell into 16 classes: amino acids; amino
acid derivatives; carbohydrates and related; energy
metabolism and related; nucleobases and related;
cholesterol, bile acids, fatty alcohols, and related;
fatty acids, glycerides (di-, and triglycerides); gly-
colipids; phospholipids; sphingolipids; catechola-
mines and other monoamines; steroids and related;
other hormones, signal substances and related;
vitamins, cofactors, and related; and miscellaneous
metabolites. None of the metabolites identiﬁed were
signiﬁcantly different between the pigs fed hLZ-
milk and those fed control milk in seven metabolite
classes (nucleobases and related; cholesterol, bile
acids, fatty alcohols, and related; glycerides; glyco-
lipids; sphingolipids; other hormones, signal sub-
stances, and related; and steroids). Levels of 18
known metabolites and 4 unknown metabolites were
signiﬁcantly different in pigs given hLZ milk
compared to pigs that received control milk
(Table 1). The levels of 17 metabolites were signif-
icantly increased, while the levels of ﬁve metabo-
lites were decreased.
Discussion
Differences in diet, nutrition, and health can be
reﬂected in the proﬁle of serum metabolites in an
organism. We have previously shown that pasteur-
ized hLZ-containing milk from transgenic goats can
positively affect the health of young pigs by changing
the bacterial composition and improving the mor-
phology of the GI tract (Brundige et al. 2008; Maga
et al. 2006b). The results of this metabolic proﬁling
experiment further support the hypothesis that con-
sumption of hLZ-containing milk imparts positive
health beneﬁts to the young animal.
Amino acids
We found that methionine and threonine, both
essential amino acids, were signiﬁcantly increased
in hLZ-milk fed pigs as compared to controls.
Methionine and its metabolite products play critical
roles in a number of cellular functions including
immune response, DNA/RNA synthesis and repair,
and a number of other biochemical reactions neces-
sary for normal cellular function (Grimble and
Grimble 1998; Grimble 2006; Lu and Mato 2008).
Threonine, like methionine, is important to immune
defense as high levels are needed to support protein
synthesis during the acute phase of immune response
(Faure et al. 2007). Threonine is also important to gut
health as increased levels correlate to increased
synthesis of mucosal proteins important for main-
taining intestinal mass and integrity (Nichols and
Bertolo 2008). Increased demand for methionine and
threonine during illness results in a decrease in
plasma concentrations. The increased levels that we
observed are consistent with a less activated immune
system, in which fewer immune responses are
necessary to ﬁght invading pathogens.
Amino acid derivatives
Four amino acid derivatives signiﬁcantly differed
between the two groups of pigs. The levels of 3-
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123hydroxyindole (minor: 3-indoxylsulfuric acid) and
urea were signiﬁcantly lower in pigs fed hLZ
transgenic milk while trans-4-hydroxyproline and
citrulline were increased. If inadequate levels of
amino acids are present in the diet, the body
catabolizes proteins, which leads to an increase in
urea production (Singh 2007). Multiple studies in
pigs have shown that decreased muscle catabolism
correlates to a decrease in serum and plasma levels of
urea (Vann et al. 2000; Davis et al. 2004; Bush et al.
2002; Dunshea et al. 1992). The decrease in urea in
the hLZ-milk fed pigs is indicative of decreased
muscle catabolism and increased utilization of amino
acids.
3-Hydroxyindole is an intermediate in the conver-
sion of tryptophan to indoxyl sulfate by gut micro-
biota (Sims and Renwick 1985; Gillam et al. 2000).
Indoxyl sulfate is a toxic compound that can
contribute to renal failure (Banoglu and King 2002)
and cause oxidative stress in endothelial cells (Dou
et al. 2007). Although indoxyl sulfate was lower, it
was not signiﬁcantly so (hLZ/control median ratio,
0.797, P = 0.301). The lower level of 3-hydroxyin-
dole is likely a result of a changed microbiota in the
Table 1 Signiﬁcant known metabolite changes observed between hLZ-fed and control-fed pigs
Metabolite hLZ
mean ± SD
Control
mean ± SD
hLZ
median
Control
median
Median ratio
(hLZ/control)
Median ratio
P value
Amino acids
Methionine 0.991 ± 0.102 0.605 ± 0.083 0.885 0.543 1.464 0.003
Threonine 0.942 ± 0.089 0.730 ± 0.062 0.877 0.712 1.201 0.039
Amino acid derivatives
3-Hydroxyindole
a 0.336 ± 0.097 0.625 ± 0.108 0.367 0.618 0.587 0.001
Urea 0.689 ± 0.062 0.999 ± 0.093 0.685 0.919 0.686 0.008
trans-4-hydroxyproline 1.078 ± 0.065 0.826 ± 0.066 1.112 0.829 1.345 0.012
Citrulline 1.359 ± 0.106 0.962 ± 0.132 1.386 0.950 1.440 0.049
Carbohydrates and related
1,5-Anhydrosorbitol 1.249 ± 0.051 0.833 ± 0.083 1.287 0.820 1.545 0.002
Scyllo-inositol 0.820 ± 0.102 0.602 ± 0.082 0.801 0.575 1.330 0.035
Myo-inositol 0.675 ± 0.124 0.467 ± 0.103 0.650 0.471 1.393 0.041
Energy metabolism and related
Alpha-ketoglutarate 1.249 ± 0.132 0.795 ± 0.116 1.187 0.799 1.492 0.024
Fatty acids
Arachidonic acid 1.116 ± 0.038 0.919 ± 0.070 1.135 0.929 1.236 0.027
Phospholipids
Phosphatidylcholine #2
b 1.059 ± 0.046 0.930 ± 0.027 1.035 0.915 1.113 0.035
Catecholamines
3-Methoxytyrosine 37.400 ± 0.020 40.567 ± 0.029 37.500 40.500 0.924 0.038
Vitamins, co-factors, and related
Coenzyme Q10 1.148 ± 0.053 0.700 ± 0.164 1.132 0.639 1.618 0.014
Miscellaneous
Taurine 1.210 ± 0.163 0.651 ± 0.088 1.135 0.624 1.745 0.011
Benzoic acid 0.936 ± 0.021 1.031 ± 0.027 0.946 1.011 0.918 0.014
2-Hydroxybutyrate 1.044 ± 0.088 0.769 ± 0.036 1.066 0.752 1.386 0.015
Creatinine 0.874 ± 0.042 1.035 ± 0.052 0.862 0.988 0.832 0.024
a Measurement may include a possible contribution from 3-indoxylsulfuric acid
b Structure annotation is based on strong analytical evidence (combinations of chromatography, mass spectrometry, chemical
reactions, deuterium-labeling, database and literature search, as well as comparisons to similar/homologue/isomeric reference
compounds)
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123GI tract. While the decrease of a precursor for a toxic
compound is desirable in terms of health, the full
extent of changes in gut microbiota populations is
unknown at this point.
Hydroxyproline is a major component of collagen,
where it helps to maintain stability (Krane 2008).
Although it is found in few other mammalian proteins,
hydroxyproline is notably present in elastin and the
C1q fraction of complement (Haskell and Johnston
1991). Because hydroxyproline is formed from a post-
translational modiﬁcation, free hydroxyproline in
bioﬂuids comes primarily from the breakdown of
collagen and elastin, although C1q may also contrib-
ute a signiﬁcant amount (Garnero and Delmas 1996).
Collagen break-down products in serum are a marker
of bone resorption, but they can also come from
collagen degradation due to inﬂammation (Weinber-
ger et al. 2005). Bone remodeling and turnover is high
during stages of rapid growth (Szulc et al. 2000), such
as occurs in young pigs; however increased growth as
measured by body weight was not observed in the
hLZ-milk fed pigs (Brundige et al. 2008). Similarly,
we saw no evidence of a systemic immune response in
hLZ-milk fed pigs as measured by changes in white
blood cell counts (Brundige et al. 2008), nor did we
see changes in the levels of mRNA of key tissue
regulators of inﬂammation (unpublished data). Thus,
the signiﬁcance of increased levels of trans-4-
hydroxyproline in the hLZ-milk fed pigs is unclear,
although it likely reﬂects the remodeling of bone and
other connective tissue during growth.
Citrulline is produced both during the urea cycle
and from the oxidation of arginine by nitric oxide
synthases (Muriel 2000). Citrulline is a marker of
intestinal absorption and function, with increased
levels correlating with increased absorptive function
(Jianfengetal.2005).Increasedserumcitrullinelevels
are also correlated to morphology changes and
increases in absorptive surface area of the intestine
(Santarpia et al. 2008; Crenn et al. 2008), such as seen
in the hLZ-milk fed pigs (Brundige et al. 2008). Thus,
the increased level of citrulline observed in the serum
of the hLZ-milk fed pigs is consistent with improved
GI health.
Carbohydrates and related
1,5-Anhydrosorbitol, scyllo-inositol, and myo-inosi-
tol were higher in hLZ-fed animals than in controls.
1,5-Anhydrosorbitol comes primarily from food, is
easily absorbed by the intestine, and is found in all
tissues (Yamanouchi et al. 1992). Although the
physiological role of 1,5-anhydrosorbitol is not
known, it is currently used as a biomarker to assess
glycemic control (Dungan 2008). Due to competition
with glucose reabsorption in the kidney, decreases in
1,5-anhydrosorbitol indicate hyperglycemic excur-
sions with levels above the renal threshold for
glucosuria (Dungan 2008). Increased levels of 1,5-
anhydrosorbitol may indicate improved glycemic
control although glucose levels did not differ in this
study (hLZ/control Median Ratio, 1.061, P = 0.348).
It is worth noting that glucose and other carbohy-
drates show great ﬂuctuation depending on when
food was last consumed and that the pigs in this study
had ad libitum access to dry feed and the time of last
dry food intake prior to sample collection is not
known.
Myo-inositol is present in a wide variety of foods,
including grains, fruits, vegetables, and nuts (Cle-
ments and Darnell 1980). Scyllo-inositol is an isomer
of myo-inositol that is found free in small amounts
and incorporated into phytic acid in plants (Anderson
and Wolter 1966). Myo-inositol is readily absorbed
by the intestine (Clements and Reynertson 1977), and
increasing its dietary availability positively correlates
to increased serum levels (Clements and Darnell
1980). Although myo-inositol can be synthesized in
vivo from glucose-6-phosphate (Holub 1982), a
portion of inositol comes from phytate degradation
by certain species of intestinal bacteria (Steer et al.
2004; Rodriguez et al. 1999). The increases seen in
the hLZ transgenic milk-fed pigs could possibly be
due to changed bacterial composition in the GI tract,
with an increase in species possessing phytase ability.
Although the change was not signiﬁcant, phosphate
levels in the pigs who consumed hLZ-containing milk
showed a slight, near-signiﬁcant increase (hLZ/con-
trol median ratio, 1.117, P = 0.059). The increased
serum levels seen for both scyllo- and myo-inositol
may have some health beneﬁts. For example, scyllo-
inositol has been shown to reverse memory deﬁcit in
transgenic mice with an Alzheimer’s phenotype
(Fenili et al. 2007). Myo-inositol has a number of
physiological effects including preventing fatty liver,
reducing cholesterol, and improving calcium absorp-
tion (Pallauf and Rimbach 1997). Myo-inositol
metabolites also function as critical secondary
568 Transgenic Res (2010) 19:563–574
123messengers in cell signaling (Downes and Macphee
1990).
Energy metabolism and related
Alpha-ketoglutarate, an energy metabolite, was
increased in hLZ-fed animals. Alpha-ketoglutarate
is formed during the Krebs cycle and can also be
synthesized by certain anaerobic bacteria, including
several species of Bacteriodes (Allison et al. 1979).
Increased levels have been associated with a number
of beneﬁts including: increased bone growth as
measured by the length of the 6th rib in pigs
(Andersen et al. 2008), decreased cholesterol levels
in rats (Radzki et al. 2009), protection of gut mucosa
and kidney function (Dabek et al. 2005), and possible
prevention of inappropriate muscle catabolism during
times of stress, such as surgery, injury and illness
(Wiren et al. 2002). As with several other observed
metabolite differences, the increase in alpha ketoglu-
tarate is likely due to changes in the composition of
the intestinal microbe population.
Fatty acids
Arachidonic acid (ARA) was the only fatty acid
measured which was signiﬁcantly different, being
elevated in the hLZ-milk fed pigs. ARA is a precursor
of inﬂammatory mediators and is involved in the
function of several organs and systems either directly
or via conversion to eicosanoids (Khanapure et al.
2007; Pompeia et al. 2003). Increased levels of ARA
metabolites are usually considered harmful as they
can lead to enhanced aggregation of platelets, endo-
peroxides, and thromboxanes (Khanapure et al.
2007). As previously mentioned, qRT-PCR data did
not show increases in key pro-inﬂammatory cyto-
kines in intestinal tissue (unpublished data), nor did
complete blood count data or pathology results
indicate an inﬂammatory response (Brundige et al.
2008). ARA is also critically important for proper
brain and neural development during infancy and
early childhood, particularly in the ﬁrst 2 years when
brain growth is most rapid (Kurlak and Stephenson
1999; Martinez 1992). Although neonates can syn-
thesize ARA, it is needed at such high levels that it is
considered a dietary essential fatty acid (Salem et al.
1996; Wainwright 2002). Because lipid metabolism
in young pigs is similar (Innis 1993) and brain growth
patterns and timing are similar between young pigs
and humans, pigs are often considered a good model
species for use in assessing links between nutrition
and brain development (Innis 1993; Dobbing and
Sands 1979). Huang et al. (2007) have shown that
increasing ARA in the diet of young pigs causes
plasma levels to also rise. Given the histological and
metabolic indicators of improved absorptive capacity
of the GI tract, the higher level of ARA observed in
the hLZ-fed pigs could potentially be due to
increased absorption in the intestine.
The serum levels of phosphatidylcholine #2 and
the DOPA catabolite 3-methoxytyrosine were also
signiﬁcantly altered, but the possible signiﬁcance of
these changes are not known.
Vitamins, co-factors, and related
Serum levels of co-enzyme Q10 were signiﬁcantly
increased in hLZ-fed animals. Co-enzyme Q10 has
multiple critical roles in normal cellular function and
maintenance (Littarru and Tiano 2007). It serves as
an electron carrier in the mitochondrial respiratory
chain; is one of the most important lipophilic
antioxidants, preventing oxidative damage to cells
and DNA; helps to prevent atherosclerosis and other
cardiovascular problems; and has neuroprotective
properties (Littarru and Tiano 2007; Young et al.
2007). Studies also indicate that co-enzyme Q10 is
required for proper function and maintenance of the
immune system. Serum levels of co-enzyme Q10
decrease in many pathologic conditions, such as
cancer, AIDS, and asthma (Folkers et al. 1997, 1988;
Gazdik et al. 2002). Additionally, co-enzyme Q10 is
necessary to support appropriate levels of circulating
T4 lymphocytes and IgG antibodies (Folkers et al.
1993), both of which play important roles in immune
defense (Majlessi et al. 2008; Goldman et al. 1985).
Because of its large size and hydrophobic properties,
absorption of co-enzyme Q10 is somewhat limited in
the intestine (Zhang et al. 1995). The increase seen
here may be due to greater intestinal absorption by
the pigs fed hLZ-containing milk or to altered co-
enzyme Q10 synthesis.
Miscellaneous metabolites
Taurine and 2-hydroxybutyrate were increased in
hLZ-milk fed pigs, while benzoic acid and creatinine
Transgenic Res (2010) 19:563–574 569
123were decreased. Taurine is considered essential in
pre-term and newborn infants (Verner et al. 2007),
and plays a necessary role in many cellular and
physiological processes (Bouckenooghe et al. 2006).
Taurine conjugates with bile acids to form bile salts
needed for the absorption of fatty acids and fat
soluble vitamins (Verner et al. 2007). Decreased
immune system activity is associated with increased
levels of circulating taurine (Stapleton et al. 1998),
further supporting the interpretation of a less acti-
vated immune system in the hLZ-milk fed animals.
Benzoic acid is produced as a by-product of
phenylalanine metabolism in bacteria or when gut
bacteria process polyphenols ingested from fruits and
beverages. It is commonly used as a food preservative
and is generally recognized as safe. Current evidence
is unclear if benzoic acid has any affect on health,
either positive or negative (Nair 2001). 2-Hydroxy-
butyrate (2-hydroxybutryic acid) is synthesized by GI
tract bacteria, Fusobacterium vivarium (Potrykus
et al. 2008). It is also unclear what affect this
increase might have on health. The decrease in
benzoic acid and increase in 2-hydroxybutyrate are
both likely indicators of changed bacterial composi-
tion of the GI tract in the hLZ-milk fed pigs.
Creatinine is produced when creatine phosphate is
broken down in muscle (Wyss and Kaddurah-Daouk
2000). Serum creatinine levels are positively corre-
lated with muscle mass (Wyss and Kaddurah-Daouk
2000), but elevated levels can also be indicative of
impaired renal function (Rule 2007). It is unclear
what the relatively lower level of creatinine in the
hLZ-fed pigs may indicate.
Summary
We found 18 known and 4 unknown metabolites
whose levels in serum were signiﬁcantly affected by
the consumption of hLZ-containing milk from trans-
genic goats. Of the 18 known metabolites, 14 were
changed in a direction consistent with improved
health of the animal, although one, ARA, could also
possibly be interpreted as a negative (Table 2). The
affects of the remaining four (phosphatidylcholine
#2, 3-methoxytyrosine, 2-hydroxybutyrate, and ben-
zoic acid) are unclear.
The serum levels of six metabolites (2-hydroxy-
butyrate, 3-hydroxyindole, myo-inositol, scyllo-ino-
sitol, alpha-ketoglutarate, and benzoic acid) most
likely reﬂect changes in the bacterial composition of
Table 2 Summary of area
of impact, direction of
change (increased : or
decreased ;), and probable
direction of impact (positive
? or negative -) for
signiﬁcantly altered
metabolites
Area of impact Metabolite Direction of
change
Direction of
impact
GI microbial composition Benzoic acid ; Neutral
2-Hydroxybutyrate : Neutral
3-Hydroxyindole ; ?
Myo and scyllo-inositol : ?
Healthier GI tract Threonine : ?
Citrulline : ?
Taurine : ?
a-Ketoglutarate : ?
Increased growth Methionine : ?
Threonine : ?
Urea ; ?
Creatinine ; ?/-
Hydroxyproline : ?
a-Ketoglutarate : ?
Immune system Methionine : ?
Threonine : ?
Taurine : ?
Coenzyme Q10 : ?
Arachidonic acid : ?/-
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123the GI tract as a result of hLZ milk consumption and,
therefore, the composition of metabolites available
for absorption. While it is not clear if there are any
consequences from the increased level of 2-hydroxy-
butyrate or decreased level of benzoic acid, there are
systemic beneﬁts to increased levels of scyllo-inosi-
tol, myo-inositol, and alpha-ketoglutarate, while
decreased levels of 3-hydroxyindol may have a
beneﬁt in reduced production of the cellular toxin
indoxyl sulfate.
The direction of change of four metabolites
(methionine, threonine, hydroxyproline, and urea)
suggests increased growth in the pigs reared on hLZ
milk. Decreased levels of urea indicate less muscle
catabolism, while increased methionine and threonine
reﬂect a greater availability for protein synthesis. The
increase in hydroxyproline may suggest enhanced
skeletal development.
Changes in four metabolites (threonine, citrulline,
taurine, and alpha-ketoglutarate) support improved
GI health. Taurine and alpha-ketoglutarate are helpful
in protecting the gut mucosal surface, while threonine
is important for maintaining intestinal mass and
integrity. Increased levels of citrulline are a marker of
increased intestinal absorption, which correlates to
our previous ﬁnding of increased villi width and
presumptively surface area in the duodenum (Brun-
dige et al. 2008). Additionally, increases in ARA and
coenzyme Q10 may be due to the suggested increase
in absorptive capacity of the intestine.
Signiﬁcant differences in levels of ﬁve metabo-
lites (methionine, threonine, taurine, coenzyme Q10,
and ARA) are associated with the immune system.
The increase in ARA could be a negative as it is
associated with increased inﬂammation and eicosa-
noids; however, CBC, qRT-PCR data, and pathol-
ogy results do not support this. However, increases
in methionine, threonine, and taurine suggests that
the immune systems of the pigs fed hLZ-containing
milk were less active than those of the pigs reared
on control milk. Also, the increase in coenzyme
Q10 may be beneﬁcial in supporting adequate
levels of important T4 lymphocytes and IgG
antibodies.
In summary, the observed changes in serum levels
of 15 of the 18 known metabolites support our
previous ﬁndings and our hypothesis that the con-
sumption of hLZ-containing milk from transgenic
goats provides positive health beneﬁts. While these
results are encouraging, the observations to date
clearly suggest that the metabolic changes in animals
consuming hLZ-containing milk need to be more
fully characterized. We have proposed that changes
in intestinal microbe population, increased absorption
of nutrients from the diet by the intestine, or less
immune system activity are driving the differences in
metabolite proﬁles. Additional studies are needed to
determine if these speculative causes are indeed
behind the changed metabolites or if other mecha-
nisms are responsible. Also, changes in the metabo-
lite proﬁle need to be determined under various
conditions, particularly during acute challenge with
enteropathogenic organisms.
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